Rivaroxaban's Role in PAD Management: Where Do We Stand?

UPMC

J. Hornick

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Perioperative Management of Anticoagulants: Podiatry Education Series

Michigan Medicine - Podiatry

M. Munson

Medical Management of Peripheral Arterial Disease

NY Endovascular Summit

H. Kamran

Risk Factors and Medical Management of PAD

Jefferson Health

T. Galanis

Clot Chronicles: Peripheral Artery Disease — What Clinicians Should …

The North American Thrombosis Forum (NATF)

M. Mcdermott

Biggest Vascular Papers/Presentations of 2022-2023

ARCH Advanced Revascularization Symposium

C. Walker

Cervical Artery Dissection: Diagnosis, Treatment and Outcomes Panel …

World Stroke Organization

V. Pujol Lereis, S. Salehi Omran, S. Yaghi, S. Engelter, H. Markus

PAD in Patients with (a Risk of) Cardiometabolic Disease: What Is th…

Cardiometabolic Health Congress (CMHC)

D. Bhatt

ICU Management for COVID 19 Patients: What Are the Anticoagulation S…

37th Annual Advances in Heart Disease

A. Gomez, P. Hsue

VOYAGER PAD Trial: Protecting the Patient Undergoing Lower Extremity…

Marc Bonaca

Medical Management of PAD: Current Data and Recommendations

NY Endovascular Summit

J. Olin

Update on Antiplatelet and Antithrombotic Use in Atherosclerosis

NY Endovascular Summit

R. Mehran, A. Lee, P. Krishnan

Femoropopliteal Artery Disease and Treatment Options / Literature Re…

NY Endovascular Summit

S. Parikh

Maximal Medical Therapy in Peripheral Arterial Disease

NY Endovascular Summit

D. Kadian-Dodov

ESC 2024 Insights: Apixaban vs Clopidogrel on a Background of Aspiri…

ESC 2024 Insights

Treating Peripheral Artery Disease: Beyond Intervention

NY Endovascular Summit

J. Olin

Peripheral Artery Disease: Hard to Detect and Treat

Houston Methodist DeBakey Heart and Vascular Center

J. P. Cooke

DOAC-Associated Bleeding Management

PERT Consortium 2021

D. Siegal